Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23891952 | 0.77 | LOXL2 (0.31) | — | |
| SCHEMBL1763464 | 0.76 | NPC1 (0.38) | — | |
| SCHEMBL8994063 | 0.76 | XDH (0.34) | IMPDH2 | |
| SCHEMBL11407432 | 0.76 | XDH (0.30) | — | |
| SCHEMBL11306419 | 0.73 | DHFR (0.42) | IMPDH2 | |
| SCHEMBL175905 | 0.72 | — | — | |
| SCHEMBL10998624 | 0.71 | IMPDH2 (0.35) | IMPDH2 | |
| SCHEMBL29376868 | 0.71 | — | — | |
| SCHEMBL10824003 | 0.71 | KDM4E (0.42) | — | |
| SCHEMBL10630213 | 0.71 | ALDH1A1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11707483-B2 | Micellic assemblies | UNIVERSITY OF WASHINGTON (US) | 2023-07-25 | — | — | US | disclosed |
| US-20200147121-A1 | MICELLIC ASSEMBLIES | UNIVERSITY OF WASHINGTON (US) | 2020-05-14 | — | — | US | disclosed |
| US-10420790-B2 | Micellic assemblies | UNIVERSITY OF WASHINGTON (US) | 2019-09-24 | — | — | US | disclosed |
| US-10195284-B2 | Compositions and methods for controlled localized delivery of bone forming therapeutic agents | UNIVERSITY OF ROCHESTER (US) | 2019-02-05 | — | — | US | disclosed |
| US-10066043-B2 | ω-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization | UNIVERSITY OF WASHINGTON (US) | 2018-09-04 | — | — | US | disclosed |
| US-9949950-B2 | Compositions and methods for controlled localized delivery of bone forming therapeutic agents | UNIVERSITY OF ROCHESTER (US) | 2018-04-24 | — | — | US | disclosed |
| US-20170239360-A1 | MICELLIC ASSEMBLIES | UNIVERSITY OF WASHINGTON (US) | 2017-08-24 | — | — | US | disclosed |
| US-9662403-B2 | Micellic assemblies | UNIVERSITY OF WASHINGTON (US) | 2017-05-30 | — | — | US | disclosed |
| US-20170145141-A1 | OMEGA-FUNCTIONALIZED POLYMERS, JUNCTION-FUNCTIONALIZED BLOCK COPOLYMERS, POLYMER BIOCONJUGATES, AND RADICAL CHAIN EXTENSION POLYMERIZATION | UNIVERSITY OF WASHINGTON (US) | 2017-05-25 | — | — | US | disclosed |
| US-20170072062-A1 | Compositions and Methods for Controlled Localized Delivery of Bone Forming Therapeutic Agents | UNIVERSITY OF ROCHESTER | 2017-03-16 | — | — | US | disclosed |
| WO-2009140432-A2 | MICELLES FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140429-A2 | MICELLIC ASSEMBLIES | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140423-A2 | TARGETED POLYMER BIOCONJUGATES | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140421-A2 | POLYMERIC CARRIER | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| CN-101437943-A | Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease | BALTIC TECHNOLOGY DEV LTD (EE) | 2009-05-20 | — | — | CN | disclosed |
| EP-2013344-A2 | ANTISENSE AGENTS COMBINING STRONGLY BOUND BASE - MODIFIED OLIGONUCLEOTIDE AND ARTIFICIAL NUCLEASE | Baltic Technology Development, Ltd. (EE) | 2009-01-14 | — | — | EP | disclosed |
| US-20070259830-A1 | Antisense Agents Combining Strongly Bound Base-Modified Oligonucleotide and Artificial Nuclease | BALTIC TECHNOLOGY DEVELOPMENT (EE) | 2007-11-08 | — | — | US | disclosed |
| WO-2007125173-A2 | ANTISENSE AGENTS COMBINING STRONGLY BOUND BASE - MODIFIED OLIGONUCLEOTIDE AND ARTIFICIAL NUCLEASE | BALTIC TECHNOLOGY DEVELOPMENT, LTD. (EE) | 2007-11-08 | — | — | WO | disclosed |
| US-5596091-A | DNA AND RNA FOR GENE EXPRESSION FOR DIAGNOSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-01-21 | — | — | US | disclosed |
| US-5491264-A | IMINIATION OF ISOPHORONE NITRILE USING REFRATORY OXIDE SUPPORTED HETEROPOLY ACID CATALYST TO FORM KETIMINE FOLLOWED BY REDUCTION OF KETIMINE TO ISOPHORONEDIAMINE IN PRESENCE OF HYDROGENATION CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11707483-B2 | Micellic assemblies | UACA, CLPTM1L, BPHL | IMPDH2 905/4885 |
| US-20070259830-A1 | Antisense Agents Combining Strongly Bound Base-Modified Oligonucleotide and Artificial Nuclease | NCL, RNGTT, POLRMT | IMPDH2 1340/4885 |
| US-10420790-B2 | Micellic assemblies | UACA, CLPTM1L, BPHL | IMPDH2 905/4885 |
| US-20200147121-A1 | MICELLIC ASSEMBLIES | CLPX, VCL, ANXA5 | IMPDH2 3261/4885 |
| US-20170239360-A1 | MICELLIC ASSEMBLIES | UACA, CLPTM1L, BPHL | IMPDH2 905/4885 |
| US-10066043-B2 | ω-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization | FASN, ALOX5, FGB | IMPDH2 4208/4885 |
| US-20170145141-A1 | OMEGA-FUNCTIONALIZED POLYMERS, JUNCTION-FUNCTIONALIZED BLOCK COPOLYMERS, POLYMER BIOCONJUGATES, AND RADICAL CHAIN EXTENSION POLYMERIZATION | FASN, ALOX5, ELOVL3 | IMPDH2 4187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.